D-310-2013 Class III Terminated

Recalled by Reckitt Benckiser Inc — Parsippany, NJ

FDA drug recall D-310-2013 was initiated by Reckitt Benckiser Inc on Mar 18, 2013 and is designated Class III. Reason for recall: Subpotent Drug: Product did not conform to the 18-month stability test specification for active Free Benzocaine. The recall status is terminated (terminated Aug 14, 2014). Affected quantity: 27,718 cases 16 count and 7,551 cases 576 count.

Recall details

Product Type
Drugs
Report Date
May 8, 2013
Initiation Date
Mar 18, 2013
Termination Date
Aug 14, 2014
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
27,718 cases 16 count and 7,551 cases 576 count

Product description

Cherry Cepacol Sore Throat Lozenges, Benzocaine 15 mg | Menthol 3.6 mg, a)16-count, NDC 63824-711-16 b) Institutional Size, 576-count, NDC 63824-711-98, OTC, Dist. by: Reckitt Benckiser, Parsippany, NJ 07054

Reason for recall

Subpotent Drug: Product did not conform to the 18-month stability test specification for active Free Benzocaine.

Distribution pattern

Nationwide

Code information

16 count: AG156 Exp 11/13, AG257 Exp 12/13, AH388 02/14, AJ167 03/14, AL367 Exp 05/14, AL555 & AL568 Exp 06/14, AM141 Exp 07/14. 576 Count: AK505 Exp 04/14, AK570 Exp 05/14, AH368 & AH398 Exp 02/14, AJ000 Exp 03/14, AG596 Exp 12/13,

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-310-2013
openFDA file date
Nov 19, 2026
Loaded by RegDataLab
Nov 20, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Need the full FDA record for Reckitt Benckiser Inc? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.

Get a free API key

How the connector works

Source: openFDA record for D-310-2013. Report a data issue: hello@regdatalab.com.